Drug Shortage Assistance Award
As part of FDA’s work to prevent and mitigate drug shortages, the Agency has created the FDA Drug Shortage Assistance Award to provide public recognition to drug companies and manufacturers who have demonstrated a commitment to preventing or alleviating drug shortages of medically necessary drugs. This award recognizes efforts of drug companies and manufacturers who have worked in cooperation with FDA and have implemented strategies to help provide a steady supply of medically necessary drugs for patients at a time when critical drug shortages pose a challenge for health care providers and patients nationwide, while maintaining a commitment to quality manufacturing.
| Company | FDA Letter |
|---|---|
| Sagent Pharmaceuticals | Award Letter (PDF - 125 KB) |
| Apotex | Award Letter (PDF - 402 KB) |
| Fresenius Kabi USA, LLC | Award Letter (PDF - 352 KB) |
| Teva | Award Letter (PDF - 352 KB) |
| ADIENNE Pharma & Biotech | Award Letter (PDF - 76 KB) |
| Eurohealth International Sàrl, a subsidiary of Hikma Pharmaceuticals | Award Letter (PDF - 29 KB) |
| Clinigen Group plc | Award Letter (PDF - 32 KB) |
| Guerbet Group | Award Letter (PDF - 32 KB) |